Summit Therapeutics SMMT
NASDAQ SMMT
$15.47 -0.08 (-0.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Price to Earnings (2018 - 2019)

Updated

Summit Therapeutics' Price to Earnings came in at 1.98 for Q2 2019.

Analysis

Summit Therapeutics (SMMT) Price to Earnings (2018 - 2019) Analysis & Trends

For FY2018, Summit Therapeutics' Price to Earnings was 2.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Summit Therapeutics 12.05 Bn 9.81 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2019 1.98
Mar 31, 2019 3.20
Oct 31, 2018 79.11
Jul 31, 2018 15.37
API Access

Summit Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SMMT&period=max&api_key=YOUR_API_KEY